Thus, this study aimed to conduct a systematic review of the current evidence on the effects of DPP-4 inhibitors on glycemic control (HbA1c, TIR), insulin dose, and β-cell function (C-peptide) in T1DM. The gene discussed is INS; the disease is type 1 diabetes mellitus.